Pre-order Enquiry
Request Free Sample
Global T-Cell Immunotherapy Market Insights, Forecast to 2028
SKU ID : QYR-20393855 | Publishing Date : 04-Mar-2022
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global T-Cell Immunotherapy Market Insights, Forecast to 2028
1 Report Business Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global T-Cell Immunotherapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 CAR-T
1.2.3 TCR
1.2.4 TIL Therapies
1.3 Market by Application
1.3.1 Global T-Cell Immunotherapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Stomach Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Esophagus Cancer
1.3.6 Pancreatic Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global T-Cell Immunotherapy Market Perspective (2017-2028)
2.2 T-Cell Immunotherapy Growth Trends by Region
2.2.1 T-Cell Immunotherapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 T-Cell Immunotherapy Historic Market Size by Region (2017-2022)
2.2.3 T-Cell Immunotherapy Forecasted Market Size by Region (2023-2028)
2.3 T-Cell Immunotherapy Market Dynamics
2.3.1 T-Cell Immunotherapy Industry Trends
2.3.2 T-Cell Immunotherapy Market Drivers
2.3.3 T-Cell Immunotherapy Market Challenges
2.3.4 T-Cell Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top T-Cell Immunotherapy Players by Revenue
3.1.1 Global Top T-Cell Immunotherapy Players by Revenue (2017-2022)
3.1.2 Global T-Cell Immunotherapy Revenue Market Share by Players (2017-2022)
3.2 Global T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by T-Cell Immunotherapy Revenue
3.4 Global T-Cell Immunotherapy Market Concentration Ratio
3.4.1 Global T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by T-Cell Immunotherapy Revenue in 2021
3.5 T-Cell Immunotherapy Key Players Head office and Area Served
3.6 Key Players T-Cell Immunotherapy Product Solution and Service
3.7 Date of Enter into T-Cell Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 T-Cell Immunotherapy Breakdown Data by Type
4.1 Global T-Cell Immunotherapy Historic Market Size by Type (2017-2022)
4.2 Global T-Cell Immunotherapy Forecasted Market Size by Type (2023-2028)
5 T-Cell Immunotherapy Breakdown Data by Application
5.1 Global T-Cell Immunotherapy Historic Market Size by Application (2017-2022)
5.2 Global T-Cell Immunotherapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America T-Cell Immunotherapy Market Size (2017-2028)
6.2 North America T-Cell Immunotherapy Market Size by Type
6.2.1 North America T-Cell Immunotherapy Market Size by Type (2017-2022)
6.2.2 North America T-Cell Immunotherapy Market Size by Type (2023-2028)
6.2.3 North America T-Cell Immunotherapy Market Share by Type (2017-2028)
6.3 North America T-Cell Immunotherapy Market Size by Application
6.3.1 North America T-Cell Immunotherapy Market Size by Application (2017-2022)
6.3.2 North America T-Cell Immunotherapy Market Size by Application (2023-2028)
6.3.3 North America T-Cell Immunotherapy Market Share by Application (2017-2028)
6.4 North America T-Cell Immunotherapy Market Size by Country
6.4.1 North America T-Cell Immunotherapy Market Size by Country (2017-2022)
6.4.2 North America T-Cell Immunotherapy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe T-Cell Immunotherapy Market Size (2017-2028)
7.2 Europe T-Cell Immunotherapy Market Size by Type
7.2.1 Europe T-Cell Immunotherapy Market Size by Type (2017-2022)
7.2.2 Europe T-Cell Immunotherapy Market Size by Type (2023-2028)
7.2.3 Europe T-Cell Immunotherapy Market Share by Type (2017-2028)
7.3 Europe T-Cell Immunotherapy Market Size by Application
7.3.1 Europe T-Cell Immunotherapy Market Size by Application (2017-2022)
7.3.2 Europe T-Cell Immunotherapy Market Size by Application (2023-2028)
7.3.3 Europe T-Cell Immunotherapy Market Share by Application (2017-2028)
7.4 Europe T-Cell Immunotherapy Market Size by Country
7.4.1 Europe T-Cell Immunotherapy Market Size by Country (2017-2022)
7.4.2 Europe T-Cell Immunotherapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific T-Cell Immunotherapy Market Size (2017-2028)
8.2 Asia-Pacific T-Cell Immunotherapy Market Size by Type
8.2.1 Asia-Pacific T-Cell Immunotherapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific T-Cell Immunotherapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific T-Cell Immunotherapy Market Share by Type (2017-2028)
8.3 Asia-Pacific T-Cell Immunotherapy Market Size by Application
8.3.1 Asia-Pacific T-Cell Immunotherapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific T-Cell Immunotherapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific T-Cell Immunotherapy Market Share by Application (2017-2028)
8.4 Asia-Pacific T-Cell Immunotherapy Market Size by Region
8.4.1 Asia-Pacific T-Cell Immunotherapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific T-Cell Immunotherapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America T-Cell Immunotherapy Market Size (2017-2028)
9.2 Latin America T-Cell Immunotherapy Market Size by Type
9.2.1 Latin America T-Cell Immunotherapy Market Size by Type (2017-2022)
9.2.2 Latin America T-Cell Immunotherapy Market Size by Type (2023-2028)
9.2.3 Latin America T-Cell Immunotherapy Market Share by Type (2017-2028)
9.3 Latin America T-Cell Immunotherapy Market Size by Application
9.3.1 Latin America T-Cell Immunotherapy Market Size by Application (2017-2022)
9.3.2 Latin America T-Cell Immunotherapy Market Size by Application (2023-2028)
9.3.3 Latin America T-Cell Immunotherapy Market Share by Application (2017-2028)
9.4 Latin America T-Cell Immunotherapy Market Size by Country
9.4.1 Latin America T-Cell Immunotherapy Market Size by Country (2017-2022)
9.4.2 Latin America T-Cell Immunotherapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa T-Cell Immunotherapy Market Size (2017-2028)
10.2 Middle East & Africa T-Cell Immunotherapy Market Size by Type
10.2.1 Middle East & Africa T-Cell Immunotherapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa T-Cell Immunotherapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa T-Cell Immunotherapy Market Share by Type (2017-2028)
10.3 Middle East & Africa T-Cell Immunotherapy Market Size by Application
10.3.1 Middle East & Africa T-Cell Immunotherapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa T-Cell Immunotherapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa T-Cell Immunotherapy Market Share by Application (2017-2028)
10.4 Middle East & Africa T-Cell Immunotherapy Market Size by Country
10.4.1 Middle East & Africa T-Cell Immunotherapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa T-Cell Immunotherapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Adaptimmune
11.1.1 Adaptimmune Company Details
11.1.2 Adaptimmune Business Overview
11.1.3 Adaptimmune T-Cell Immunotherapy Introduction
11.1.4 Adaptimmune Revenue in T-Cell Immunotherapy Business (2017-2022)
11.1.5 Adaptimmune Recent Developments
11.2 Altor Bioscience Corporation
11.2.1 Altor Bioscience Corporation Company Details
11.2.2 Altor Bioscience Corporation Business Overview
11.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Introduction
11.2.4 Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2017-2022)
11.2.5 Altor Bioscience Corporation Recent Developments
11.3 Cellectis
11.3.1 Cellectis Company Details
11.3.2 Cellectis Business Overview
11.3.3 Cellectis T-Cell Immunotherapy Introduction
11.3.4 Cellectis Revenue in T-Cell Immunotherapy Business (2017-2022)
11.3.5 Cellectis Recent Developments
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Details
11.4.2 Juno Therapeutics Business Overview
11.4.3 Juno Therapeutics T-Cell Immunotherapy Introduction
11.4.4 Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2017-2022)
11.4.5 Juno Therapeutics Recent Developments
11.5 Kite Pharma
11.5.1 Kite Pharma Company Details
11.5.2 Kite Pharma Business Overview
11.5.3 Kite Pharma T-Cell Immunotherapy Introduction
11.5.4 Kite Pharma Revenue in T-Cell Immunotherapy Business (2017-2022)
11.5.5 Kite Pharma Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis T-Cell Immunotherapy Introduction
11.6.4 Novartis Revenue in T-Cell Immunotherapy Business (2017-2022)
11.6.5 Novartis Recent Developments
11.7 Takara Bio
11.7.1 Takara Bio Company Details
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio T-Cell Immunotherapy Introduction
11.7.4 Takara Bio Revenue in T-Cell Immunotherapy Business (2017-2022)
11.7.5 Takara Bio Recent Developments
11.8 Unum Therapeutics
11.8.1 Unum Therapeutics Company Details
11.8.2 Unum Therapeutics Business Overview
11.8.3 Unum Therapeutics T-Cell Immunotherapy Introduction
11.8.4 Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2017-2022)
11.8.5 Unum Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Figures, Tables and Charts Available in Global T-Cell Immunotherapy Market Insights, Forecast to 2028
List of TablesTable 1. Global T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of CAR-T
Table 3. Key Players of TCR
Table 4. Key Players of TIL Therapies
Table 5. Global T-Cell Immunotherapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global T-Cell Immunotherapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global T-Cell Immunotherapy Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global T-Cell Immunotherapy Market Share by Region (2017-2022)
Table 9. Global T-Cell Immunotherapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global T-Cell Immunotherapy Market Share by Region (2023-2028)
Table 11. T-Cell Immunotherapy Market Trends
Table 12. T-Cell Immunotherapy Market Drivers
Table 13. T-Cell Immunotherapy Market Challenges
Table 14. T-Cell Immunotherapy Market Restraints
Table 15. Global T-Cell Immunotherapy Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global T-Cell Immunotherapy Revenue Share by Players (2017-2022)
Table 17. Global Top T-Cell Immunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Immunotherapy as of 2021)
Table 18. Ranking of Global Top T-Cell Immunotherapy Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by T-Cell Immunotherapy Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players T-Cell Immunotherapy Product Solution and Service
Table 22. Date of Enter into T-Cell Immunotherapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global T-Cell Immunotherapy Revenue Market Share by Type (2017-2022)
Table 26. Global T-Cell Immunotherapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global T-Cell Immunotherapy Revenue Market Share by Type (2023-2028)
Table 28. Global T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global T-Cell Immunotherapy Revenue Share by Application (2017-2022)
Table 30. Global T-Cell Immunotherapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global T-Cell Immunotherapy Revenue Share by Application (2023-2028)
Table 32. North America T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America T-Cell Immunotherapy Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America T-Cell Immunotherapy Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America T-Cell Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America T-Cell Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe T-Cell Immunotherapy Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe T-Cell Immunotherapy Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe T-Cell Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe T-Cell Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific T-Cell Immunotherapy Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific T-Cell Immunotherapy Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific T-Cell Immunotherapy Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific T-Cell Immunotherapy Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America T-Cell Immunotherapy Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America T-Cell Immunotherapy Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America T-Cell Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America T-Cell Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa T-Cell Immunotherapy Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa T-Cell Immunotherapy Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa T-Cell Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa T-Cell Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
Table 62. Adaptimmune Company Details
Table 63. Adaptimmune Business Overview
Table 64. Adaptimmune T-Cell Immunotherapy Product
Table 65. Adaptimmune Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 66. Adaptimmune Recent Developments
Table 67. Altor Bioscience Corporation Company Details
Table 68. Altor Bioscience Corporation Business Overview
Table 69. Altor Bioscience Corporation T-Cell Immunotherapy Product
Table 70. Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 71. Altor Bioscience Corporation Recent Developments
Table 72. Cellectis Company Details
Table 73. Cellectis Business Overview
Table 74. Cellectis T-Cell Immunotherapy Product
Table 75. Cellectis Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 76. Cellectis Recent Developments
Table 77. Juno Therapeutics Company Details
Table 78. Juno Therapeutics Business Overview
Table 79. Juno Therapeutics T-Cell Immunotherapy Product
Table 80. Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 81. Juno Therapeutics Recent Developments
Table 82. Kite Pharma Company Details
Table 83. Kite Pharma Business Overview
Table 84. Kite Pharma T-Cell Immunotherapy Product
Table 85. Kite Pharma Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 86. Kite Pharma Recent Developments
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis T-Cell Immunotherapy Product
Table 90. Novartis Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 91. Novartis Recent Developments
Table 92. Takara Bio Company Details
Table 93. Takara Bio Business Overview
Table 94. Takara Bio T-Cell Immunotherapy Product
Table 95. Takara Bio Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 96. Takara Bio Recent Developments
Table 97. Unum Therapeutics Company Details
Table 98. Unum Therapeutics Business Overview
Table 99. Unum Therapeutics T-Cell Immunotherapy Product
Table 100. Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 101. Unum Therapeutics Recent Developments
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global T-Cell Immunotherapy Market Share by Type: 2021 VS 2028
Figure 2. CAR-T Features
Figure 3. TCR Features
Figure 4. TIL Therapies Features
Figure 5. Global T-Cell Immunotherapy Market Share by Application: 2021 VS 2028
Figure 6. Stomach Cancer Case Studies
Figure 7. Lung Cancer Case Studies
Figure 8. Colorectal Cancer Case Studies
Figure 9. Esophagus Cancer Case Studies
Figure 10. Pancreatic Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. T-Cell Immunotherapy Report Years Considered
Figure 13. Global T-Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global T-Cell Immunotherapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global T-Cell Immunotherapy Market Share by Region: 2021 VS 2028
Figure 16. Global T-Cell Immunotherapy Market Share by Players in 2021
Figure 17. Global Top T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Immunotherapy as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by T-Cell Immunotherapy Revenue in 2021
Figure 19. North America T-Cell Immunotherapy Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America T-Cell Immunotherapy Market Size Market Share by Type (2017-2028)
Figure 21. North America T-Cell Immunotherapy Market Size Market Share by Application (2017-2028)
Figure 22. North America T-Cell Immunotherapy Market Size Share by Country (2017-2028)
Figure 23. United States T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe T-Cell Immunotherapy Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe T-Cell Immunotherapy Market Size Market Share by Type (2017-2028)
Figure 27. Europe T-Cell Immunotherapy Market Size Market Share by Application (2017-2028)
Figure 28. Europe T-Cell Immunotherapy Market Size Share by Country (2017-2028)
Figure 29. Germany T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific T-Cell Immunotherapy Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific T-Cell Immunotherapy Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific T-Cell Immunotherapy Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific T-Cell Immunotherapy Market Size Share by Region (2017-2028)
Figure 39. China T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 45. Latin America T-Cell Immunotherapy Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America T-Cell Immunotherapy Market Size Market Share by Type (2017-2028)
Figure 47. Latin America T-Cell Immunotherapy Market Size Market Share by Application (2017-2028)
Figure 48. Latin America T-Cell Immunotherapy Market Size Share by Country (2017-2028)
Figure 49. Mexico T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa T-Cell Immunotherapy Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa T-Cell Immunotherapy Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa T-Cell Immunotherapy Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa T-Cell Immunotherapy Market Size Share by Country (2017-2028)
Figure 55. Turkey T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Adaptimmune Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022)
Figure 59. Altor Bioscience Corporation Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022)
Figure 60. Cellectis Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022)
Figure 61. Juno Therapeutics Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022)
Figure 62. Kite Pharma Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022)
Figure 63. Novartis Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022)
Figure 64. Takara Bio Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022)
Figure 65. Unum Therapeutics Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Keyplayers in Global T-Cell Immunotherapy Market Insights, Forecast to 2028
AdaptimmuneAltor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics
